EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, Mind Medicine's enterprise value is $539.77 Mil.
Mind Medicine's EBITDA for the trailing twelve months (TTM) ended in Dec. 2023 was $-90.71 Mil. Therefore, Mind Medicine's EV-to-EBITDA for today is -5.95.
The historical rank and industry rank for Mind Medicine's EV-to-EBITDA or its related term are showing as below:
MNMD'
s EV-to-EBITDA Range Over the Past 10 Years
Min: -56.65 Med: 0 Max: 1.16
Current: -5.95
During the past 4 years, the highest EV-to-EBITDA of Mind Medicine was 1.16. The lowest was -56.65. And the median was 0.00.
MNMD's EV-to-EBITDA is ranked worse than 100% of 473
companies
in the Biotechnology industry
Industry Median: 9.22
vs MNMD: -5.95
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.
As of today (2024-04-25), Mind Medicine's stock price is $8.46.
Mind Medicine's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 was $-2.450. Therefore, Mind Medicine's PE Ratio for today is At Loss.
The "classic" EV-to-EBITDA is much better in capturing debt and net cash than the PE Ratio.
Mind Medicine EV-to-EBITDA Historical Data
The historical data trend for Mind Medicine's EV-to-EBITDA can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Mind Medicine's EV-to-EBITDA
For the Biotechnology subindustry, Mind Medicine's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Mind Medicine's EV-to-EBITDA Distribution in the Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Mind Medicine's EV-to-EBITDA distribution charts can be found below:
* The bar in red indicates where Mind Medicine's EV-to-EBITDA falls into.
Mind Medicine EV-to-EBITDA Calculation
Mind Medicine's EV-to-EBITDA for today is calculated as:
Mind Medicine's current Enterprise Value is $539.77 Mil.
Mind Medicine's EBITDA for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $-90.71 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Mind Medicine (NAS:MNMD) EV-to-EBITDA Explanation
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.
Mind Medicine's PE Ratio for today is calculated as:
Mind Medicine's share price for today is $8.46.
Mind Medicine's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $-2.450.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio.
Thank you for viewing the detailed overview of Mind Medicine's EV-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.
Mind Medicine (Mind Medicine) Business Description
Mind Medicine Inc is a psychedelic medicine biotech company that discovers, develops, and deploys psychedelic inspired medicines and therapies to address addiction and mental illness. The company is assembling a compelling drug development pipeline of treatments based on psychedelic substances including Psilocybin, LSD, MDMA, DMT, and an Ibogaine derivative, 18-MC. The firm is having an approach towards developing the next generation of psychedelic inspired medicines and therapies.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
MNMD has been successfully added to your 